{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:01:32Z","timestamp":1784750492649,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.beem.2021.101575","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T11:13:29Z","timestamp":1631272409000},"page":"101575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Menopausal hormone therapy in women with benign gynaecological conditions and cancer"],"prefix":"10.1016","volume":"35","author":[{"given":"Annabelle","family":"Brennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.beem.2021.101575_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of the North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101575_bib2","series-title":"Menopause: diagnosis and management guideline","first-page":"1","year":"2015"},{"key":"10.1016\/j.beem.2021.101575_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/medicina55080477","article-title":"Hormonal replacement therapy in menopausal women with history of endometriosis: a review of literature","volume":"55","author":"Zanello","year":"2019","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.beem.2021.101575_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/humupd\/dmx011","article-title":"The management of menopause in women with a history of endometriosis: a systematic review","volume":"23","author":"Gemmell","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.beem.2021.101575_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0015-0282(01)02981-8","article-title":"Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy","volume":"77","author":"Matorras","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2021.101575_bib6","series-title":"Endometriosis \u2013 management after menopause","year":"2019"},{"key":"10.1016\/j.beem.2021.101575_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.beem.2021.101575_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.beem.2021.101575_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.beem.2021.101575_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/medicina55090549","article-title":"The impact of hormonal replacement treatment in postmenopausal women with uterine fibroids: a state-of-the-art review of the literature","volume":"55","author":"Moro","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.beem.2021.101575_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1289\/ehp.00108s5791","article-title":"Advances in uterine leiomyoma research: the progesterone hypothesis","volume":"108","author":"Rein","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.beem.2021.101575_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/GCO.0000000000000185","article-title":"Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution","volume":"27","author":"Moravek","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101575_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0015-0282(16)58098-4","article-title":"The effects of hormone replacement therapy on uterine fibroids in postmenopausal women","volume":"65","author":"Sener","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2021.101575_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(00)00159-6","article-title":"Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT","volume":"37","author":"Polatti","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101575_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(01)00588-7","article-title":"Effect of different doses of progestin on uterine leiomyomas in postmenopausal women","volume":"102","author":"Palomba","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.beem.2021.101575_bib16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/GME.0000000000001105","article-title":"Hormone therapy in menopausal women with fibroids. Is it safe?","volume":"25","author":"Srinivasan","year":"2018","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.beem.2021.101575_bib17","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2018.05.004","article-title":"The comparing options for management: PAtient-centered REsults for uterine fibroids (COMPARE-UF) registry: rationale and design","volume":"219","author":"Stewart","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101575_bib18","article-title":"Uterine smooth muscle tumour of uncertain malignant potential (STUMP): where are we now?","volume":"26","author":"Ganesan","year":"2020","journal-title":"Case Rep Womens Health"},{"key":"10.1016\/j.beem.2021.101575_bib19","series-title":"Cancer facts","year":"2019"},{"key":"10.1016\/j.beem.2021.101575_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/GME.0000000000000508","article-title":"Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis","volume":"23","author":"Pergialiotis","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101575_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.beem.2021.101575_bib22","article-title":"Hormone replacement therapy after surgery for epithelial ovarian cancer","author":"Saeaib","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2021.101575_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/pgp.0b013e31803025cd","article-title":"Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis","volume":"26","author":"Wong","year":"2007","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.beem.2021.101575_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ygyno.2012.02.037","article-title":"Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum","volume":"125","author":"Gershenson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.beem.2021.101575_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0000000000001396","article-title":"Hormone use after nonserous epithelial ovarian cancer: overall and disease-free survival","volume":"127","author":"Power","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2021.101575_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.beem.2021.101575_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jcp.2006.040030","article-title":"Ovarian clear cell adenocarcinoma: a continuing enigma","volume":"60","author":"Tan","year":"2007","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.beem.2021.101575_bib28","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","year":"2004","journal-title":"J\u00a0Am Med Assoc"},{"issue":"6","key":"10.1016\/j.beem.2021.101575_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/GME.0000000000000611","article-title":"Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration","volume":"23","author":"Bergandal","year":"2016","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.beem.2021.101575_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/ijgc-2020-002032","article-title":"Management of menopausal symptoms and ovarian function preservation in women with gynecological cancer","volume":"31","author":"Brennan","year":"2021","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.beem.2021.101575_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2014.03.573","article-title":"Hormone therapy in ovarian granulosa cell tumors: a systematic review","volume":"134","author":"van Meurs","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.beem.2021.101575_bib32","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1200\/JCO.2006.08.4590","article-title":"Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study","volume":"25","author":"Gershenson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.beem.2021.101575_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ijgc-2019-001105","article-title":"Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged \u226440 years","volume":"30","author":"Son","year":"2020","journal-title":"Int J Gynecol Canc"},{"issue":"5","key":"10.1016\/j.beem.2021.101575_bib34","article-title":"Hormone replacement therapy for women previously treated for endometrial cancer","author":"Edey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.beem.2021.101575_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Gynecologic Oncology Group Study. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2021.101575_bib36","series-title":"EMAS care online 2020","author":"Menopause","year":"2020"},{"key":"10.1016\/j.beem.2021.101575_bib38","first-page":"3045","article-title":"Sex steroids and cervical cancer","volume":"32","author":"Hellberg","year":"2012","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.beem.2021.101575_bib39","first-page":"1341","article-title":"Patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters","volume":"30","author":"Bodner","year":"2010","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.beem.2021.101575_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13697137.2020.1826426","article-title":"Hormone replacement therapy and cervical cancer: a systematic review of the literature","volume":"24","author":"Vargiu","year":"2021","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.beem.2021.101575_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ygyno.2017.09.009","article-title":"Hormone replacement therapy after treatment for cervical cancer: are we adhering to standard of care?","volume":"147","author":"Rauh","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.beem.2021.101575_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000357","article-title":"Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study","volume":"22","author":"Everhov","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2021.101575_bib43","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/humrep\/deaa124","article-title":"Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies","volume":"35","author":"Zhu","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.beem.2021.101575_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psyneuen.2019.03.013","article-title":"Surgical menopause in association with cognitive function and risk of dementia: a systematic review and meta-analysis","volume":"106","author":"Georgakis","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.beem.2021.101575_bib45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2019.06.017","article-title":"Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: society of gynecologic oncology and American society for reproductive medicine evidence- based review","volume":"155","author":"Chen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.beem.2021.101575_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo- oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.beem.2021.101575_bib47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:10Z","timestamp":1761497830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1521690X21000920"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101575","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone therapy in women with benign gynaecological conditions and cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101575"}}